HAYA Therapeutics
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome. The company leverages its proprietary platform to uncover new insights into disease-associated cell states and the long non-coding RNAs (lncRNAs) that control them. Its lead candidate, HTX-001, is being developed as a potential treatment for heart failure. In addition, the company is advancing a pipeline of precision therapies that target lncRNAs for cell-specific treatment of conditions affecting other tissues.
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does HAYA Therapeutics use?+
HAYA Therapeutics uses 18 technologies including WP Rocket, WordPress, GSAP.
What industry is HAYA Therapeutics in?+
HAYA Therapeutics operates in the Biotechnology industry.
Where is HAYA Therapeutics based?+
HAYA Therapeutics is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026